|
[1]BIOLAC-SAGE P, BALABAUD C, WANLESS I.Focal nodular hyperplasia and hepatocellular adenoma[M]//BOSMAN FT, CARNEIRO F, HRUBAN RH, et al.World Health Organization classification of tumours of the digestive system.Lyon:IARC Press, 2010:198-204.[2]ROOKS JB, ORY HW, ISHAK KG, et al.Epidemiology of hepatocellular adenoma.The role of oral contraceptive use[J].JAMA, 1979, 242 (7) :644-648.[3]van AALTEN SM, TERKIVATAN T, de MAN RA, et al.Diagnosis and treatment of hepatocellular adenoma in the Netherlands:similarities and differences[J].Dig Surg, 2010, 27 (1) :61-67.[4]LIN H, van den ESSCHERT J, LIU C, et al.Systematic review of hepatocellular adenoma in China and other regions[J].J Gastroenterol Hepatol, 2011, 26 (1) :28-35.[5]CONG WM.Hepatocellular adenocarcinoma[M]//CONG WM, ZHU SN.Diagnostic surgical pathology of hepatobiliary tumors.Shanghai:Shanghai Scientific Technological Education Publishing House, 2011:79-87. (in Chinese) 丛文铭.肝细胞腺瘤[M]//丛文铭, 朱世能.肝胆肿瘤诊断外科病理学.上海:上海科技教育出版社, 2001:79-87.[6]BIOULAC-SAGE P, REBOUISSOU S, THOMAS C, et al.Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry[J].Hepatology, 2007, 46 (3) :740-748.[7]JEANNOT E, POGRIBNY IP, BELAND FA, et al.Chronic administration of ethanol leads to an increased incidence of hepatocellular adenoma by promoting H-ras-mutated cells[J].Cancer Lett, 2011, 301 (2) :161-167.[8]JEANNOT E, MELLOTTEE L, BIOULAC-SAGE P, et al.Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage[J].Diabetes, 2010, 59 (7) :1836-1844.[9]REZNIK Y.Hepatocyte nuclear factor-1 gene inactivation:cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY) 3 families[J].J Clin Endocrinol Metab, 2004, 89 (3) :1476-1480.[10]KISHNANI PS, CHUANG TP, BALI D, et al.Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease[J].Hum Mol Genet, 2009, 18 (24) :4781-4790.[11]BIOULAC-SAGE P, TAOUJI S, POSSENTI L, et al.Hepatocellular adenoma subtypes:the impact of overweight and obesity[J].Liver Int, 2012, 32 (8) :1217-1221.[12]CHANG CY, HERNANDEZ-PRERA JC, ROAYAIE S, et al.Changing epidemiology of hepatocellular adenoma in the United States:review of the literature[J].Int J Hepatol, 2013, 2013:604860.[13]BUNCHORNTAVAKUL C, BAHIRWANI R, DRAZEK D, et al.Clinical features and natural history of hepatocellular adenomas:the impact of obesity[J].Aliment Pharmacol Ther, 2011, 34 (6) :664-674.[14]PARADIS V, CHAMPAULT A, RONOT M, et al.Telangiectatic adenoma:an entity associated with increased body mass index and inflammation[J].Hepatology, 2007, 46 (1) :140-146.[15]STARLEY BQ, CALCAGNO CJ, HARRISON SA.Nonalcoholic fatty liver disease and hepatocellular carcinoma:a weighty connection[J].Hepatology, 2010, 51 (5) :1820-1832.[16]WAKE DJ, STRAND M, RASK E, et al.Intra-adipose sex steroid metabolism and body fat distribution in idiopathic human obesity[J].Clin Endocrinol (Oxf) , 2007, 66 (3) :440-446.[17]SASAKI M, YONEDA N, KITAMURA S, et al.Characterization of hepatocellular adenoma based on the phenotypic classification:The Kanazawa experience[J].Hepatol Res, 2011, 41 (10) :982-988.[18]ZUCMAN-ROSSI J, JEANNOT E, NHIEU JT, et al.Genotypephenotype correlation in hepatocellular adenoma:new classification and relationship with HCC[J].Hepatology, 2006, 43 (3) :515-524.[19]BIOULAC-SAGE P, BALABAUD C, ZUCMAN-ROSSI J.Subtype classification of hepatocellular adenoma[J].Dig Surg, 2010, 27 (1) :39-45.[20]MICCHELLI ST, VIVEKANANDAN P, BOITNOTT JK, et al.Malignant transformation of hepatic adenomas[J].Mod Pathol, 2008, 21 (4) :491-497.[21]REBOUISSOU S, AMESSOU M, COUCHY G, et al.Frequent inframe somatic deletions activate gp130 in inflammatory hepatocellular tumours[J].Nature, 2009, 457 (7226) :200-204.[22]PAN J, CONG WM.Analysis on loss of heterozygosity of four tumor suppressor genes in hepatocellular adenoma[J].J Clin Exp Pathol, 2003, 19 (5) :481-483. (in Chinese) 潘晶, 丛文铭.肝细胞腺瘤肿瘤抑制基因杂合性缺失分析[J].临床与实验病理学杂志, 2003, 19 (5) :481-483.[23]NAULT JC, BIOULAC-SAGE P, ZUCMAN-ROSSI J.Hepatocellular benign tumors-from molecular classification to personalized clinical care[J].Gastroenterology, 2013, 144 (5) :888-902.
|
DownLoad: